Alicia is an experimental scientist who specialized in Biotechnology at the Universidad Autónoma de Madrid. She also holds a Master’s degree in the Pharma & Biotech field, which provided her with a comprehensive understanding of how scientific innovation can be translated into real improvements in patient care.
Her early career was shaped by research at two leading institutions in Spain: the National Center for Biotechnology (CNB), and IMDEA Nanoscience, where she worked on projects in virology and neurodegenerative diseases. Her research culminated in a co‑authored scientific article on Amyotrophic Lateral Sclerosis (ALS), marking an important milestone in her career. This dedication was also deeply personal, as a close family situation with neurodegenerative diseases inspired her to continue her career in neuroscience.
Motivated by her desire to break down access barriers to treatments, Alicia transitioned into the pharmaceutical industry. She joined a Japanese global pharmaceutical company, working on national projects with treatments in cardiovascular diseases designed to prevent strokes.
Alicia quickly realized the importance of combining science with strategy to ensure that innovation reaches patients.
Her commitment to public health also led her to volunteer with the “Freno al Ictus" foundation, delivering stroke awareness talks in schools to educate young people about prevention and early recognition of stroke. This experience deeply resonated with her values, reinforcing her belief that science must be brought closer to society.
When she discovered the opportunity to join the Angels Initiative, Alicia recognized it as a project unlike any other. Here, consultants have the chance to take ownership of their regions, address real-world barriers to improve stroke care, and contribute to a global movement that proves change is possible.
She says, “Joining Angels means contributing to a mission that goes beyond individual roles. It is about building stroke‑ready hospitals, improving treatment quality, and proving that together we can transform patient care. For me, it is an inspiring opportunity to give life a chance.”